Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Dec 5, 2022--
The "Global 3D Cell culture Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The global 3D cell culture market is growing at a considerable CAGR of 11.0% during the forecast period. Rising demand for organ transplantation is one of the prime factors affecting and driving the market.
Companies Mentioned
Cost effective along with time saving culture technique, broad range of application among others is also estimated to be the prime factors that are contributing significantly towards the growth of the market. However, unclear regulation in some countries along with high cost involvement in tissue engineering are some major factors constraints which are hindering the growth of the global 3D cell culture market across the globe.
However, increasing funding from the government along with private investors is one of the key factors that are creating opportunity in the market. New launches in the market are likely to drive the growth of the global 3D cell culture market.
For instance, in April 2021, Biogelx had recently put forward scientific reports in which it had highlighted about Peptide based scaffolds that has a focal point with the proper usage of peptide that is based hydrogels as scaffolds for primary liver cells as 3D cell culture. Around 600 million people suffer from liver disease across the globe and this hydrogel offering would be useful in these regards.
Regional Outlooks
The global 3D cell culture market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in 2020 in the global 3D cell culture market.
Some factors that are boosting the market growth in North America are high expenditure in healthcare along with investment in R&D. Additionally, increasing number of cases due to cancer in the region and presence of universities and research organization that are involved in various cell based approaches are some of the other factor that are driving the growth of the market in this region.
Asia-Pacific will have Considerable Growth in the Global 3D Cell Culture Market
Asia-Pacific region is expected to witness significant growth opportunities for the market. Increasing prevalence of various types of cancer in emerging economies of the region are likely to drive the growth of the regional market. Further due to increasing demand for the R&D projects in India, China and South Korea are also some of the factors that are affecting and impacting the growth in this market.
The Report Covers
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19on Key Players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global 3D Cell Culture Market by Product
5.1.1. Scaffold-Based 3d Cell Culture
5.1.2. Scaffold-Free 3d Cell Culture
5.1.3. Other
5.2. Global 3D Cell Culture Market by Application
5.2.1. Cancer and Stem Cell Research
5.2.2. Drug Discovery
5.2.3. Toxicology
5.2.4. Tissue Engineering & Regenerative Medicine
5.3. Global 3D Cell Culture Market by EndUser
5.3.1. Pharmaceutical & Biotechnology Companies
5.3.2. Research Institutes
5.3.3. Other
6. Regional Analysis
7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/pvtra6
View source version on businesswire.com:https://www.businesswire.com/news/home/20221205005394/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/05/2022 07:46 AM/DISC: 12/05/2022 07:47 AM
http://www.businesswire.com/news/home/20221205005394/en